iberogast: Clinical Trials

2 trials of iberogast, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2

Follow iberogast: new trials by email Literature Review of iberogast trials Research Report on iberogast

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Prove of Concept Study, to Evaluate the Efficacy, Safety, and Tolerability of IBEROGAST in the Treatment of Bowel Troubles in Patients With Parkinson's Disease
IBEROGAST - Gastrointestinal Disorders in Parkinson's Disease
Phase 2CompletedNantes University Hospital452016-04-012026-09-14
Study in Patients Suffering From Heartburn and Backward Flow of Stomach Liquid Into the Esophagus
STW5 (Iberogast®, BAY98-7411), Placebo - Functional Gastrointestinal Disorders
Phase 2CompletedBayer642009-06-182019-09-19

Conditions studied

Gastrointestinal Diseases (1)

Sponsors

Bayer (1)  ·  Nantes University Hospital (1)

Countries

France (1)  ·  Germany (1)

Results publications

PMID 32829914

NIH funding

2008 (1)